Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
57.7 USD | -0.53% | +4.18% | -15.09% |
Sales 2024 * | 230M 286M | Sales 2025 * | 244M 304M | Capitalization | 2.34B 2.92B |
---|---|---|---|---|---|
Net income 2024 * | -71M -88.5M | Net income 2025 * | -90M -112M | EV / Sales 2024 * | 8.92 x |
Net cash position 2024 * | 293M 365M | Net cash position 2025 * | 219M 273M | EV / Sales 2025 * | 8.7 x |
P/E ratio 2024 * |
-37.3
x | P/E ratio 2025 * |
-26.4
x | Employees | 497 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.6% |
Latest transcript on Immunocore Holdings plc
1 day | -0.31% | ||
1 week | +4.18% | ||
Current month | -10.75% | ||
1 month | -5.92% | ||
3 months | -17.10% | ||
6 months | +26.36% | ||
Current year | -15.09% |
Managers | Title | Age | Since |
---|---|---|---|
Bahija Jallal
CEO | Chief Executive Officer | 62 | 18-12-31 |
Brian DiDonato
DFI | Director of Finance/CFO | 57 | 20-03-31 |
John Trainer
COO | Chief Operating Officer | 50 | 23-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Perez
BRD | Director/Board Member | 59 | 19-08-31 |
John Bell
CHM | Chairman | 71 | 15-02-28 |
Bahija Jallal
CEO | Chief Executive Officer | 62 | 18-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 1,026 M€ | +6.88% | - | |
0.18% | 0 M€ | 0.00% | - | |
0.14% | 5 M€ | +7.05% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 58.01 | +0.02% | 82 069 |
24-04-25 | 58 | -0.80% | 496,622 |
24-04-24 | 58.47 | +2.02% | 394,870 |
24-04-23 | 57.31 | +2.67% | 302,166 |
24-04-22 | 55.82 | +0.25% | 295,838 |
Delayed Quote Nasdaq, April 26, 2024 at 11:03 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.09% | 2.93B | |
+26.13% | 653B | |
+27.00% | 556B | |
-6.51% | 354B | |
+20.29% | 331B | |
+3.92% | 296B | |
+12.88% | 233B | |
+5.57% | 201B | |
-9.65% | 193B | |
-6.34% | 144B |
- Stock Market
- Equities
- IMCR Stock